4//SEC Filing
Simonian Nancy A 4
Accession 0000950170-24-133338
CIK 0001556263other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:00 PM ET
Size
4.9 KB
Accession
0000950170-24-133338
Insider Transaction Report
Form 4
Simonian Nancy A
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-02$0.27/sh−37,070$10,016→ 4,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2680 to $0.2726, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001359574
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:00 PM ET
- Size
- 4.9 KB